Who is the CEO of Chongkundang Holdings?

According to the DART company overview, Chongkundang Holdings' representative director is 최희남 (name as registered in Korean). The company was founded on 1956-01-10.

Where is Chongkundang Holdings listed?

Chongkundang Holdings trades on the Korea Exchange KOSPI market under the ticker 001630. Its fiscal year ends in December.

Does Chongkundang Holdings pay a dividend?

Yes. For fiscal 2025, Chongkundang Holdings paid a cash dividend of ₩1,400 per common share, a 2.6% yield as stated in its annual report, with a payout ratio of 16.5%. The prior year's dividend was ₩1,400.

Does Chongkundang Holdings have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Share pledge (a 5%+ holder reported a share pledge agreement (loan, extension or change) in the past 90 days). These are factual flags, not investment advice.

Which companies are in the same industry as Chongkundang Holdings?

Under the Korean Standard Industrial Classification recorded on DART, Chongkundang Holdings is grouped with 107 other listed companies in pharmaceuticals. The most covered in Korean news over the past 30 days are Hanmi Pharm, Daewoong Pharma and GC Biopharma.

Chongkundang Holdings KRX:001630KOSPI

종근당홀딩스 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked36since Sep 11

In Q2 2026, Chongkundang Holdings reported revenue of ₩251bn, up 3.7% year on year, and operating profit of ₩6.6bn. Chongkundang Holdings (종근당홀딩스) appeared in 0 Korean news articles and 0 DART filings over the past seven days.

Filing signals Share pledge Screener

Chongkundang Holdings quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩251bn	+3.7%	₩6.6bn margin 2.6%	₩17.6bn
Q1 2026	₩240bn	-2.6%	₩19.3bn margin 8.0%	₩17.9bn
Q4 2025 derived	₩236bn	+3.9%	₩11.8bn margin 5.0%	₩15.1bn
Q3 2025	₩234bn	+0.9%	₩18.1bn margin 7.7%	₩20.0bn
Q2 2025	₩242bn	-2.5%	₩16.5bn margin 6.8%	₩11.4bn
Q1 2025	₩247bn	-1.3%	₩11.9bn margin 4.8%	₩7.8bn
Q4 2024 derived	₩227bn	+1.1%	₩6.9bn margin 3.0%	₩6.8bn
Q3 2024	₩232bn	+4.1%	₩7.5bn margin 3.2%	₩3.8bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Chongkundang Holdings top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Chongkundang Holdings news Korean headlines

Oct 2109:00

ExclusiveChong Kun Dang Holdings out of sync with U.S. business expansion on trademark registration...reasons for delay
FETV
Oct 110:55
Chong Kun Dang Holdings hosts 13th Chong Kun Dang Go-chon Art Biennial Planning Exhibition
베타뉴스
1 more on this story · 1 outlets
- Chong Kun Dang Holdings hosts 13th Chong Kun Dang Go-chon Art Biennial Planning ExhibitionCNB뉴스 · Oct 1 14:42
Sep 3022:08
Chong Kun Dang Holdings hosts 13th Chong Kun Dang Go-chon Art Biennial Planning Exhibition
비즈트리뷴
1 more on this story · 1 outlets
- Chong Kun Dang Holdings hosts 13th Chong Kun Dang Go-chon Art Biennial Planning Exhibition메디포뉴스 · Oct 1 01:53
Sep 3014:13
Chong Kun Dang Holdings 'Chong Kun Dang Gochon Art Prize' project exhibition...online exhibition also activated
파이낸셜포스트
1 more on this story · 1 outlets
- Chong Kun Dang Holdings '13th Chong Kun Dang Gochon Art Prize Project Exhibition'글로벌뉴스통신GNA · Sep 30 22:44
Sep 3014:00

Chong Kun Dang Holdings unfolds painting world of three emerging artists...'Gochon Art Prize' project exhibition
중앙이코노미뉴스
Sep 3012:28

Chong Kun Dang Holdings opens stage for three emerging artists' three-year growth...13th 'Gochon Art Prize' exhibition
경인방송
Sep 3011:54

Weekly Today industrial news_Dong-A Pharmaceutical, Chong Kun Dang Holdings (9.30)
위클리오늘
Sep 3010:44

Chong Kun Dang Holdings 'Gochon Art Prize' project exhibition...showcases 43 paintings by three emerging artists
산경투데이
Sep 3010:26
Chong Kun Dang Holdings holds painting exhibition of three emerging artists...displaying 43 pieces
뉴스1
1 more on this story · 1 outlets
- Chong Kun Dang Holdings showcases 43 works by three emerging artists이뉴스투데이 · Sep 30 15:00
Sep 3009:51

Chong Kun Dang Holdings walks with three emerging artists for three years...blooming through works
공공뉴스
Sep 3009:47

Chong Kun Dang Holdings 'Chong Kun Dang Gochon Art Prize' project exhibition...unveils works by three emerging artists
더페어뉴스
Sep 3009:35

Chong Kun Dang Holdings showcases 43 works by Park No-wan, Park Ung-kyu and Jang Pa
PRESS9
Sep 3009:25
Chong Kun Dang Holdings hosts 13th Chong Kun Dang Go-chon Art Biennial Planning Exhibition
헬스경향
18 more on this story · 18 outlets
- Chong Kun Dang Holdings to hold 'Chong Kun Dang Gochon Art Prize' project exhibition at Sejong Cultural Center브릿지경제 · Sep 30 09:28
- Chong Kun Dang Holdings hosts 13th Chong Kun Dang Go-chon Art Biennial Planning Exhibition메드월드뉴스 · Sep 30 09:36
- Chong Kun Dang Holdings opens 'Chong Kun Dang Gochon Art Prize Project Exhibition'의협신문 · Sep 30 10:12
- Chong Kun Dang Holdings to hold 13th 'Chong Kun Dang Gochon Art Prize Project Exhibition'더바이오 · Sep 30 10:42
- Chong Kun Dang Holdings to hold 'Chong Kun Dang Gochon Art Prize' project exhibition핀포인트뉴스 · Sep 30 10:45
- Chong Kun Dang Holdings holds 'Chong Kun Dang Gochon Art Prize Project Exhibition'전자신문 · Sep 30 11:01
- Chong Kun Dang Holdings to hold '13th Art Prize Project Exhibition' at Sejong Cultural Center아주경제 · Sep 30 11:54
- Chong Kun Dang Holdings to hold '13th Chong Kun Dang Gochon Art Prize Project Exhibition' Oct. 1-12에너지신문 · Sep 30 12:14
- Chong Kun Dang Holdings hosts 13th Chong Kun Dang Go-chon Art Biennial Planning Exhibition오늘경제 · Sep 30 12:34
- Chong Kun Dang Holdings to hold 'Chong Kun Dang Gochon Art Prize' project exhibition뉴스핌 · Sep 30 13:14
- Chong Kun Dang Holdings to hold 'Chong Kun Dang Gochon Art Prize' project exhibition at Sejong Cultural Center이슈밸리 · Sep 30 13:40
- Chong Kun Dang Holdings holds 'Chong Kun Dang Gochon Art Prize Project Exhibition'...Dong-A Pharmaceutical launches health supplement 'Wistro'시사오늘 · Sep 30 13:49
- +6
Sep 1516:33

Chong Kun Dang Holdings expands stake in Bell & C...to be included as subsidiary
뉴스저널리즘Stake / acquisition

Articles per day 2 weeks

Company profile

CEO: 최희남
Industry: Pharmaceuticals
Founded: 1956-01-10
Fiscal year-end: December
Head office: 서울특별시 서대문구
Website: ckd-holdings.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Chongkundang Holdings dividends annual report

Korea dividend rankings

Year	Per share	Yield	Payout
FY2025	₩1,400	2.6%	16.5%
FY2024	₩1,400	2.8%	19.8%
FY2023	₩1,400	2.4%	14.2%

Major shareholders latest 5%+ report per holder

Korea 5% stake disclosures

이장한48.09%

Each holder's most recent 5% ownership report on DART; names as filed in Korean.

Same industry Pharmaceuticals

All in industry

Company	Latest quarter op. profit	Articles 30d
Hanmi Pharm	₩37.8bn	644
Daewoong Pharma	₩71.3bn	477
GC Biopharma	–	455
Yuhan	–	410
HK inno.N	–	177
Chong Kun Dang Pharmaceutical	–	176
Jeil Pharmaceutical	–	149
DongKookPharmaceutical	–	146

Compare Chongkundang Holdings side by side with these companies

Chongkundang Holdings DART filings

Oct 1216:54

Corrected filing: Semi-annual Report (2026.06)
Other
Sep 3016:04

Report on large shareholdings in securities (general)
Ownership reports
Sep 3014:32

Corrected material event report (business suspension) (subsidiary's major business matters)
Risk & warnings

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Chongkundang Holdings FAQ

Who is the CEO of Chongkundang Holdings?: According to the DART company overview, Chongkundang Holdings' representative director is 최희남 (name as registered in Korean). The company was founded on 1956-01-10.
Where is Chongkundang Holdings listed?: Chongkundang Holdings trades on the Korea Exchange KOSPI market under the ticker 001630. Its fiscal year ends in December.
What were Chongkundang Holdings' latest quarterly results?: In Q2 2026, Chongkundang Holdings reported revenue of ₩251bn, up 3.7% year on year, and operating profit of ₩6.6bn. Figures come from reports filed on DART.
Does Chongkundang Holdings pay a dividend?: Yes. For fiscal 2025, Chongkundang Holdings paid a cash dividend of ₩1,400 per common share, a 2.6% yield as stated in its annual report, with a payout ratio of 16.5%. The prior year's dividend was ₩1,400.
Does Chongkundang Holdings have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Share pledge (a 5%+ holder reported a share pledge agreement (loan, extension or change) in the past 90 days). These are factual flags, not investment advice.
Which companies are in the same industry as Chongkundang Holdings?: Under the Korean Standard Industrial Classification recorded on DART, Chongkundang Holdings is grouped with 107 other listed companies in pharmaceuticals. The most covered in Korean news over the past 30 days are Hanmi Pharm, Daewoong Pharma and GC Biopharma.